Click on image to view larger version.

Figure 2 Images at baseline and after 12 months of treatment. After 12 months, three contiguous slices (no interslice gap) for each plaque were obtained, and the slice most closely matching the one at baseline was selected. In selected slices, arrows indicate plaques. (A) Thoracic aortic plaque that showed regression (28% vessel wall area [VWA] reduction) with 38% low-density lipoprotein-cholesterol (LDL-C) reduction by 20-mg atorvastatin; (B) thoracic plaque that showed regression (–10%) with 34% LDL-C reduction by 5 mg; (C) thoracic plaque that showed progression (+15%) with 20% LDL-C reduction by 5 mg; and (D) abdominal aortic plaque that showed progression (+9%) despite 39% LDL-C reduction by 20 mg.